FNDC5 and sarcopenia: Park et al. [47] took advantage of a cohort of 153 women to investigate the possible role of irisin as a biomarker in sarcopenia and observed that the irisin levels were lower in the sarcopenia group than in the control or pre-sarcopenia groups [47].